He is being transferred to the ICU for Afib with RVR with rates into the 170-180s, and hypotension with SBP to 82/60.
Despite an increase in metoprolol from 12.5 TID to 25 TID, his rates were still in the 140-150s all night, difficult to control.
ICU consult was called when blood pressure dipped to 82/60 in setting of persistent tachycardia.
Vitals prior to transfer to ICU were: 97.2, 98/62, 89, 20, 96%RA   Past Medical History: PAST ONCOLOGIC HISTORY: DLBCL stage IVB-E - [**5-/2194**] Developed new back pain - [**7-/2194**] Developed low grade fever of 99s and symptomatic - [**8-/2194**] Developed nightly drenching night sweats - [**2194-8-27**] Seen for above symptoms.
- [**8-29**] and [**2194-9-4**] MRI showed increased signal intensity in the marrow spaces in the spine as well as scattered enhancing lesions in several vertebrae - [**2194-9-8**] CT torso without obvious adenopathy, thoracic, abdominal, or pelvic pathology - [**2194-9-8**] Evaluated in [**Hospital 17130**] Clinic.
Found to have worsening anemia to H/H of 10.7/31.6, low reticulocyte count, new thrombocytosis to 632, elevated ferritin to 2067, rising transaminases to AST/ALT of 86/141 with an alk phos up to 174, an LDH of 588, and normal B12 and folate.
- [**2194-9-8**] Bone marrow biopsy with fibrosis and organizing bone, indeterminate.
- [**2194-9-12**] LDH up to 1664, Ca up to 10.5, ferritin 3805, CRP above assay, more anemic.
Repeat BMBx showed large atypical cells which co-express B-cell marker CD20 along with CD10 and bcl-2 C-MYC negative c/w DLBCL.
- [**2194-9-18**] C1D1 R-da-[**Hospital1 **] (Rituximab 375 mg/m2, Etoposide 50 mg/m2, DOXOrubicin 10 mg/m2, VinCRIStine 0.5 mg, Cyclophosphamide 750 mg/m2, PredniSONE 100 mg) c/b afib w RVR - [**2194-10-9**] C2D1 R-daEPOCH (Rituximab 375 mg/m2, Etoposide 60 mg/m2, DOXOrubicin 12 mg/m2, VinCRIStine 0.5 mg, Cyclophosphamide 900 mg/m2, PredniSONE 100 mg) - [**2194-10-11**] Found to have line associated DVT, line pulled and started fundaparinox - [**2194-10-20**] Admitted w trilobar PE, switched to heparin and DCed on enoxaparin - [**2194-11-3**] C1D1 R-CHOP s/p R-[**Hospital1 **] x 2 (Rituximab 375 mg/m2, Cyclophosphamide 750 mg/m2, DOXOrubicin 50 mg/m2, VinCRIStine 1.4 mg/m2 capped at 2 mg on D1 with prednisone 100 mg PO on D1-5) - [**2194-11-24**] C2D1 R-CHOP s/p R-[**Hospital1 **] x 2 (Rituximab 375 mg/m2, Cyclophosphamide 750 mg/m2, DOXOrubicin 50 mg/m2, VinCRIStine 1.4 mg/m2 capped at 2 mg on D1 with prednisone 100 mg PO on D1-5) - [**2194-12-8**] admission for C1 high dose methotrexate 3.5 g/m2 with leucovorin rescue on D15 of the R-CHOP cycle - [**2194-12-29**] Cycle #2 high-dose MTX 3.5g/m2.
OTHER MEDICAL HISTORY: - Trilobar PEs [**10/2194**] while on fundaparinox - Line associated RUE DVT [**10/2194**] - Idiopathic DVT in his 30s - Afib with RVR - OSA not on CPAP - HLD on atorvastatin and CoQ10 - Mononucleosis in his teens  Social History: - Tobacco: Rare cigars in his youth.
Physical Exam: Admission Physical Exam:  Gen: NAD, AAOx3 HEENT: MMM, OP clear, no JVD, no cervical/axillary/supraclavicular LAD, neck supple CV: irregularly irregular, S1S2, no m/r/g Chest: CTA b/l, no w/r/r Abd: Soft, NT, ND, +BS, no HSM Ext: WWP, no e/c/c Skin: No rashes or lesions Neuro: CN II-XII grossly intact, 2/2 strength throughout, normal coordination   Pertinent Results: Admission labs: WBC-3.8* RBC-3.77* HGB-12.5* HCT-36.3* MCV-96 MCH-33.1* MCHC-34.4 RDW-15.8* PLT COUNT-216 NEUTS-48* BANDS-9* LYMPHS-28 MONOS-7 EOS-0 BASOS-0 ATYPS-4* METAS-1* MYELOS-2* PROMYELO-1* HYPOCHROM-NORMAL ANISOCYT-1+ POIKILOCY-1+ MACROCYT-1+ MICROCYT-1+ POLYCHROM-NORMAL OVALOCYT-1+ BURR-OCCASIONAL .
ALBUMIN-4.4 CALCIUM-9.7 PHOSPHATE-3.8 MAGNESIUM-2.0 URIC ACID-6.8 ALT(SGPT)-44* AST(SGOT)-22 LD(LDH)-171 TOT BILI-0.3 GLUCOSE-101* UREA N-17 CREAT-1.0 SODIUM-135 POTASSIUM-4.0 CHLORIDE-99 TOTAL CO2-25 ANION GAP-15 .
Discharge Labs: [**2195-1-17**] 04:51AM BLOOD WBC-5.0 RBC-3.47* Hgb-11.6* Hct-33.3* MCV-96 MCH-33.4* MCHC-34.8 RDW-16.0* Plt Ct-228 [**2195-1-17**] 04:51AM BLOOD Neuts-87.9* Lymphs-9.1* Monos-2.2 Eos-0.6 Baso-0.3 [**2195-1-17**] 04:51AM BLOOD PT-10.6 PTT-33.9 INR(PT)-1.0 [**2195-1-17**] 04:51AM BLOOD Glucose-114* UreaN-9 Creat-0.9 Na-137 K-4.1 Cl-104 HCO3-28 AnGap-9 [**2195-1-17**] 04:51AM BLOOD ALT-72* AST-36 LD(LDH)-190 AlkPhos-68 TotBili-0.4 [**2195-1-17**] 04:51AM BLOOD Calcium-9.1 Mg-2.1 [**2195-1-17**] 06:07AM BLOOD mthotrx-0.05 [**2195-1-16**] 05:40PM BLOOD mthotrx-0.19 [**2195-1-15**] 08:50PM BLOOD mthotrx-1.0 .
URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-NEG COLOR-Straw APPEAR-Clear SP [**Last Name (un) 155**]-1.002 .
MICROBIOLOGY Urine culture [**2195-1-14**]- negative Blood culture [**2195-1-15**]- pending   Brief Hospital Course: BRIEF HOSPITAL COURSE This is a 56 year old gentleman with DLBCL on R-CHOP and HD MTX, here for 3rd cycle of HD MTX, with course complicated by hypotension, Afib with RVR following MTX infusion.
Afib with RVR - Patient has developed Afib with RVR in setting of HD MTX in the past, likely because of stress of high rate infusion of meds and fluids.
Of note, patient was ruled out for acute coronary syndrome with cardiac enzymes negative x 3.
His heart rate was controlled with uptitration of metoprolol and he was started on diltiazem with uptitration of the dose to 90 qid with prn 10mg IV for heart rate > 120.
His heart rate was ultimately controlled.
Blood cultures were sent on transfer to ICU and were negative or pending.
Has been having good urine output during the course of this admission.
Mtx levels were followed at 24, 48 and 72 hours and he was continued on bicarbonate @ 100 cc/hr.
TRANSITIONAL ISSUES: Code Status: Full Follow-up: Outpatient stress test, cardiology f/u with Dr. [**Last Name (STitle) **] Pending Studies: Blood cultures from [**1-15**]   Medications on Admission: ACYCLOVIR 400 mg Tablet TID ENOXAPARIN 80 mg/0.8 mL twice a day LORAZEPAM 1-2 mg q6h prn nausea/anxiety/insomnia METOPROLOL TARTRATE - 12.5 mg three times a day ONDANSETRON HCL - 8 mg Tablet every 8 hours as needed for nausea.
OXYCODONE 5 mg Tablet - [**2-2**] every four (4) hours as needed for pain PROCHLORPERAZINE MALEATE - 10 mg Tablet 3 times daily PRN nausea  SULFAMETHOXAZOLE-TRIMETHOPRIM DS - Monday, Wednesday, Friday ASPIRIN - 81 mg QD DOCUSATE SODIUM 100 mg Capsule [**Hospital1 **] PRN constipation PYRIDOXINE - 250 mg Tablet twice a day SENNOSIDES [SENNA] - 8.6 mg Tablet [**Hospital1 **] PRN constipation SODIUM BICARBONATE - 650 mg Tablet, 2 Tablet(s) [**Hospital1 **] for 2d PTA  Discharge Medications: 1. enoxaparin 80 mg/0.8 mL Syringe Sig: One (1)  Subcutaneous Q12H (every 12 hours).
Your course was complicated with the development of atrial fibrillation with rapid ventricular rate and low blood pressure.
Due to your rapid heart rate and low blood pressure, you were transferred to the intensive care unit for further monitoring.
In the ICU, your heart rate and blood pressure was controlled with a medication called diltiazem.
If any other symptoms develop, including light headedness, chest pain, shortness of breath, or any symptoms that concern you, please report to the emergency room.
Department: DERMATOLOGY AND LASER When: THURSDAY [**2195-5-14**] at 7:30 AM With: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 2308**], MD [**Telephone/Fax (1) 3965**] Building: [**Location (un) 3966**] ([**Location (un) 55**], MA) [**Location (un) **] Campus: OFF CAMPUS     Best Parking: Free Parking on Site .
